Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2206 in Relapsed Lymphoma
NCT01258998Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MK-2206 in lymphoma, sponsored by National Cancer Institute. Started Dec 2010; status: completed.
02
Drugs
MK-2206
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT01258998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01258998.